Deepa Ghosh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Deepa Ghosh has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
- Jijo Thomas
Chemical Biology Unit, Institute of Nano Science and Technology, Knowledge City, Sector 81, Mohali, Punjab 140306, India
16 shared publications Vineeta Panwar
Chemical Biology Unit, Institute of Nano Science and Technology, Sector-81, Mohali 140306, Punjab, India
14 shared publicationsAnjana Sharma
Chemical Biology Unit, Institute of Nano Science and Technology, Sector-81, Mohali 140306, Punjab, India
13 shared publicationsVianni Chopra
Chemical Biology Unit, Institute of Nano Science and Technology, Knowledge City, Sector 81, Mohali, Punjab 140306, India
12 shared publicationsSwati Kaushik
Chemical Biology Unit Institute of Nano Science and Technology Knowledge City, Sector 81 Mohali Punjab 140306 India
11 shared publicationsHimadri Shekhar Roy
Chemical Biology Unit, Institute of Nano Science and Technology, Mohali, India
8 shared publications
Latest Publications
- Open Access
- 8 September 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (37) , 54778-54781
Transformative Materials Research: Defining Conceptual Change across Scales
What qualifies as transformative materials research? In this Viewpoint, we use “transformative” to denote work that forces revision of underlying assumptions, enables generalization across systems, or reveals regimes inaccessible to existing frameworks. The term is widely invoked yet rarely defined with disciplinary precision. Perspectives spanning nanomaterials chemistry, catalysis, soft and bioinspired interfaces, and functional materials suggest that transformation occurs when new reaction mechanisms are uncovered, when structure–property relationships are redefined, and when operation under realistic chemical environments reveals fundamentally new governing mechanisms. Foundational insight, developmental refinement, and industrial realization constitute an interdependent value chain through which transformative discoveries mature into societal impact. Mistaking progress within a single component for a fundamental shift risks blurring the line between incremental refinement and genuine conceptual change. Transformation requires a conceptual discontinuity in at least one stage of this value chain, most commonly through foundational scientific insight, while the remaining stages enable its realization and broader impact. This Viewpoint argues that transformative materials research is defined less by topic than by intellectual pursuit, chemical and structural rigor, and sustained engagement with unexpected observations during mechanism discovery and eventual validation under realistic chemical environments and at scale.
- 8 September 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (37) , 54778-54781
Open AccessTransformative Materials Research: Defining Conceptual Change across Scales
What qualifies as transformative materials research? In this Viewpoint, we use “transformative” to denote work that forces revision of underlying assumptions, enables generalization across systems, or reveals regimes inaccessible to existing frameworks. The term is widely invoked yet rarely defined with disciplinary precision. Perspectives spanning nanomaterials chemistry, catalysis, soft and bioinspired interfaces, and functional materials suggest that transformation occurs when new reaction mechanisms are uncovered, when structure–property relationships are redefined, and when operation under realistic chemical environments reveals fundamentally new governing mechanisms. Foundational insight, developmental refinement, and industrial realization constitute an interdependent value chain through which transformative discoveries mature into societal impact. Mistaking progress within a single component for a fundamental shift risks blurring the line between incremental refinement and genuine conceptual change. Transformation requires a conceptual discontinuity in at least one stage of this value chain, most commonly through foundational scientific insight, while the remaining stages enable its realization and broader impact. This Viewpoint argues that transformative materials research is defined less by topic than by intellectual pursuit, chemical and structural rigor, and sustained engagement with unexpected observations during mechanism discovery and eventual validation under realistic chemical environments and at scale.
- 18 July 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 376, 153598
Injectable polysaccharide-based composite hydrogel promotes regeneration of critical-sized bone defects
- 18 July 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 376, 153598
Injectable polysaccharide-based composite hydrogel promotes regeneration of critical-sized bone defects
- 3 March 2026
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 18 (13) , 7193-7209
Engineering osteoinductive hydroxyapatite via zinc and strontium co-substitution
Critical-size bone defects remain a major clinical challenge due to the limited regenerative capacity of bone tissue, necessitating biomaterials that provide both structural support and biological stimulation. Synthetic hydroxyapatite (HAp) is widely used for bone repair because of its close similarity to native bone minerals; however, strategies to enhance its biological performance are actively being explored. Among these, ionic substitution—particularly with zinc (Zn2+) and strontium (Sr2+) ions—has emerged as a promising approach to promote osteogenesis while inhibiting bone resorption. Recent studies on Zn/Sr-substituted HAp have reported the formation of undesirable secondary phases, which compromise biological performance. Considering these limitations, the present study aims to synthesize phase-pure Zn- and Sr-substituted hydroxyapatite nanoparticles using a soft-template method, with careful optimization of Zn2+ and Sr2+ concentrations for bone tissue engineering applications. Accordingly, Zn-substituted, Sr-substituted, and Zn/Sr co-substituted hydroxyapatite nanoparticles (Zn-HAp, Sr-HAp, and ZnSr-HAp) were synthesised and systematically characterised. Physicochemical analysis revealed that, in comparison with single-ion substitution, Zn/Sr co-substitution significantly altered crystal nucleation and growth behaviour while preserving phase purity. Biological evaluation using bone-derived cells demonstrated that ZnSr-HAp nanoparticles were highly biocompatible and significantly enhanced cell attachment, proliferation, and matrix mineralisation compared to pristine and single ion-substituted HAp. Furthermore, ZnSr-HAp treatment markedly upregulated the expression of collagen type I (COL I) and osteocalcin (OCN), indicating the promotion of both early extracellular matrix formation and late-stage osteogenic maturation. Collectively, these findings demonstrate a synergistic effect of Zn and Sr co-substitution in enhancing the osteoinductive and osteoconductive properties of HAp. Overall, Zn/Sr co-substituted hydroxyapatite nanoparticles represent a promising bioactive platform for advanced bone regeneration applications.
- 3 March 2026
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 18 (13) , 7193-7209
Engineering osteoinductive hydroxyapatite via zinc and strontium co-substitution
Critical-size bone defects remain a major clinical challenge due to the limited regenerative capacity of bone tissue, necessitating biomaterials that provide both structural support and biological stimulation. Synthetic hydroxyapatite (HAp) is widely used for bone repair because of its close similarity to native bone minerals; however, strategies to enhance its biological performance are actively being explored. Among these, ionic substitution—particularly with zinc (Zn2+) and strontium (Sr2+) ions—has emerged as a promising approach to promote osteogenesis while inhibiting bone resorption. Recent studies on Zn/Sr-substituted HAp have reported the formation of undesirable secondary phases, which compromise biological performance. Considering these limitations, the present study aims to synthesize phase-pure Zn- and Sr-substituted hydroxyapatite nanoparticles using a soft-template method, with careful optimization of Zn2+ and Sr2+ concentrations for bone tissue engineering applications. Accordingly, Zn-substituted, Sr-substituted, and Zn/Sr co-substituted hydroxyapatite nanoparticles (Zn-HAp, Sr-HAp, and ZnSr-HAp) were synthesised and systematically characterised. Physicochemical analysis revealed that, in comparison with single-ion substitution, Zn/Sr co-substitution significantly altered crystal nucleation and growth behaviour while preserving phase purity. Biological evaluation using bone-derived cells demonstrated that ZnSr-HAp nanoparticles were highly biocompatible and significantly enhanced cell attachment, proliferation, and matrix mineralisation compared to pristine and single ion-substituted HAp. Furthermore, ZnSr-HAp treatment markedly upregulated the expression of collagen type I (COL I) and osteocalcin (OCN), indicating the promotion of both early extracellular matrix formation and late-stage osteogenic maturation. Collectively, these findings demonstrate a synergistic effect of Zn and Sr co-substitution in enhancing the osteoinductive and osteoconductive properties of HAp. Overall, Zn/Sr co-substituted hydroxyapatite nanoparticles represent a promising bioactive platform for advanced bone regeneration applications.
- 29 July 2025
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 48 (7-8) , 765-781
Curcumin monoglucuronide protects cartilage from progressive degeneration by blocking MMP-13
Collagenases (MMP-1, MMP-8, and MMP-13) play significant roles in the pathophysiology of osteoarthritis. Among these proteins, MMP-13 and MMP-8 are known for their catabolic roles in the degradation of the articular cartilage matrix. Using computational studies, we had previously observed that a metabolite of curcumin, Curcumin monoglucuronide (CMG), binds to MMPs involved in cartilage matrix destruction. The purpose of this study was to confirm the ability of CMG to protect cartilage by blocking the activity of these enzymes. The ability of CMG to bind and block the activities of MMP-13 and MMP-8 was established using several physicochemical methods. First, the protective effect of CMG on MMP-mediated cartilage destruction was demonstrated using cartilage explants in vitro. Second, the in vivo efficacy of CMG was tested by comparison with BI-4394, a specific MMP-13 inhibitor, using a rat anterior cruciate ligament transection (ACLT) model. These studies demonstrated that CMG was more effective than BI-4394 at preventing cartilage degeneration. In separate in vitro studies, CMG did not affect chondrocyte proliferation or the expression of NF-κB-mediated proinflammatory genes. Together, these findings demonstrate the therapeutic potential of CMG and emphasize the importance of inhibiting both MMP-13 and MMP-8 to achieve improved clinical outcomes.
- 29 July 2025
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 48 (7-8) , 765-781
Curcumin monoglucuronide protects cartilage from progressive degeneration by blocking MMP-13
Collagenases (MMP-1, MMP-8, and MMP-13) play significant roles in the pathophysiology of osteoarthritis. Among these proteins, MMP-13 and MMP-8 are known for their catabolic roles in the degradation of the articular cartilage matrix. Using computational studies, we had previously observed that a metabolite of curcumin, Curcumin monoglucuronide (CMG), binds to MMPs involved in cartilage matrix destruction. The purpose of this study was to confirm the ability of CMG to protect cartilage by blocking the activity of these enzymes. The ability of CMG to bind and block the activities of MMP-13 and MMP-8 was established using several physicochemical methods. First, the protective effect of CMG on MMP-mediated cartilage destruction was demonstrated using cartilage explants in vitro. Second, the in vivo efficacy of CMG was tested by comparison with BI-4394, a specific MMP-13 inhibitor, using a rat anterior cruciate ligament transection (ACLT) model. These studies demonstrated that CMG was more effective than BI-4394 at preventing cartilage degeneration. In separate in vitro studies, CMG did not affect chondrocyte proliferation or the expression of NF-κB-mediated proinflammatory genes. Together, these findings demonstrate the therapeutic potential of CMG and emphasize the importance of inhibiting both MMP-13 and MMP-8 to achieve improved clinical outcomes.
- 15 October 2024
- Published by American Chemical Society (ACS) in Energy & Fuels
- Vol. 38 (21) , 20258-20284
Advances and Outlook of Ti3C2-Based Catalysts for Electrocatalytic Hydrogen Production: A Comprehensive Overview
- 15 October 2024
- Published by American Chemical Society (ACS) in Energy & Fuels
- Vol. 38 (21) , 20258-20284
Advances and Outlook of Ti3C2-Based Catalysts for Electrocatalytic Hydrogen Production: A Comprehensive Overview
- 25 August 2024
- Published by Springer Nature
- p. 1-39
Carbon Nanotubes for Cartilage and Bone Tissue Engineering
- 25 August 2024
- Published by Springer Nature
- p. 1-39
Carbon Nanotubes for Cartilage and Bone Tissue Engineering
- 9 July 2024
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry C
- Vol. 128 (28) , 11612-11625
Unveiling the Mechanistic Aspects of Solar-Driven Hematein Remediation Using Biocompatible Metal-Free Carbon Nitride Nanosheets
- 9 July 2024
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry C
- Vol. 128 (28) , 11612-11625
Unveiling the Mechanistic Aspects of Solar-Driven Hematein Remediation Using Biocompatible Metal-Free Carbon Nitride Nanosheets
- 6 June 2024
- Published by Taylor & Francis
- p. 180-201
Nanotechnology Advancements for Improved Bone Metabolism, Regeneration and Treatment of Bone Diseases
The advent of technology has opened various avenues to study the effect of nanomedicine in the area of bone regeneration. The active or passive targeting of nanomedicine has been utilized to mechanistically elucidate the cellular metabolism pathways, as well as regeneration cascades. The use of biomaterials at nanoscale levels as scaffolds and for drug targeting has also led to the development of new strategies to visualize and recapitulate the microscopic and nanoscopic regeneration of bone. Apart from regeneration, the use of nanocarriers to deliver drugs and active molecules has also seen a wide application in bone-related diseases including, bone cancer, bone tuberculosis, osteoporosis, osteoarthritis, osteomyelitis and others. This chapter provides insight into the role of nanotechnology in bone metabolism, regeneration and disease conditions.
- 6 June 2024
- Published by Taylor & Francis
- p. 180-201
Nanotechnology Advancements for Improved Bone Metabolism, Regeneration and Treatment of Bone Diseases
The advent of technology has opened various avenues to study the effect of nanomedicine in the area of bone regeneration. The active or passive targeting of nanomedicine has been utilized to mechanistically elucidate the cellular metabolism pathways, as well as regeneration cascades. The use of biomaterials at nanoscale levels as scaffolds and for drug targeting has also led to the development of new strategies to visualize and recapitulate the microscopic and nanoscopic regeneration of bone. Apart from regeneration, the use of nanocarriers to deliver drugs and active molecules has also seen a wide application in bone-related diseases including, bone cancer, bone tuberculosis, osteoporosis, osteoarthritis, osteomyelitis and others. This chapter provides insight into the role of nanotechnology in bone metabolism, regeneration and disease conditions.
- 14 May 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (20) , 25727-25739
Silver Nanoparticle-Embedded Carbon Nitride: Antifungal Activity on Candida albicans and Toxicity toward Animal Cells
The development of engineered nanomaterials has been considered a promising strategy to control oral infections. In this study, silver-embedded carbon nitrides (Ag@g-CN) were synthesized and tested against Candida albicans, investigating their antifungal action and biocompatibility in animal cells. Ag@g-CN was synthesized by a simple one-pot thermal polymerization technique and characterized by various analytical techniques. X-ray diffraction (XRD) analysis revealed slight alterations in the crystal structure of g-CN upon the incorporation of Ag. Fourier transform infrared (FT-IR) spectroscopy confirmed the presence of Ag-N bonds, indicating successful silver incorporation and potential interactions with g-CN's amino groups. UV-vis spectroscopy demonstrated a red shift in the absorption edge of Ag@g-CN compared with g-CN, attributed to the surface plasmon resonance effect of silver nanoparticles. Field emission scanning electron microscopy (FE-SEM) and transmission electron microscopy (TEM) confirmed the 2D layered sheet like morphology of both materials. The Ag 3d peaks found in X-ray photoelectron spectroscopy (XPS) confirmed the presence of metallic Ag0 nanoparticles in Ag@g-CN. The Ag@g-CN materials exhibited high antifungal activity against reference and oral clinical strains of C. albicans, with minimal inhibitory concentration (MIC) ranges between 16-256 μg/mL. The mechanism of Ag@g-CN on C. albicans was attributed to the disruption of the membrane integrity and disturbance of the biofilm. In addition, the Ag@g-CN material showed good biocompatibility in the fibroblastic cell line and in Galleria mellonella, with no apparent cytotoxicity observed at a concentration up to 1000 μg/mL. These findings demonstrate the potential of the Ag@g-CN material as an effective and safe antifungal agent for the treatment of oral fungal infections.
- 14 May 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (20) , 25727-25739
Silver Nanoparticle-Embedded Carbon Nitride: Antifungal Activity on Candida albicans and Toxicity toward Animal Cells
The development of engineered nanomaterials has been considered a promising strategy to control oral infections. In this study, silver-embedded carbon nitrides (Ag@g-CN) were synthesized and tested against Candida albicans, investigating their antifungal action and biocompatibility in animal cells. Ag@g-CN was synthesized by a simple one-pot thermal polymerization technique and characterized by various analytical techniques. X-ray diffraction (XRD) analysis revealed slight alterations in the crystal structure of g-CN upon the incorporation of Ag. Fourier transform infrared (FT-IR) spectroscopy confirmed the presence of Ag-N bonds, indicating successful silver incorporation and potential interactions with g-CN's amino groups. UV-vis spectroscopy demonstrated a red shift in the absorption edge of Ag@g-CN compared with g-CN, attributed to the surface plasmon resonance effect of silver nanoparticles. Field emission scanning electron microscopy (FE-SEM) and transmission electron microscopy (TEM) confirmed the 2D layered sheet like morphology of both materials. The Ag 3d peaks found in X-ray photoelectron spectroscopy (XPS) confirmed the presence of metallic Ag0 nanoparticles in Ag@g-CN. The Ag@g-CN materials exhibited high antifungal activity against reference and oral clinical strains of C. albicans, with minimal inhibitory concentration (MIC) ranges between 16-256 μg/mL. The mechanism of Ag@g-CN on C. albicans was attributed to the disruption of the membrane integrity and disturbance of the biofilm. In addition, the Ag@g-CN material showed good biocompatibility in the fibroblastic cell line and in Galleria mellonella, with no apparent cytotoxicity observed at a concentration up to 1000 μg/mL. These findings demonstrate the potential of the Ag@g-CN material as an effective and safe antifungal agent for the treatment of oral fungal infections.
- Open Access
- 18 April 2024
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 12 (22) , 5325-5338
On-demand release of a selective MMP-13 blocker from an enzyme-responsive injectable hydrogel protects cartilage from degenerative progression in osteoarthritis
Release of BI-4394, a MMP-13 inhibitor, from an enzyme-responsive hydrogel protects cartilage from progressive degeneration in an ACLT rat model.
- 18 April 2024
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 12 (22) , 5325-5338
Open AccessOn-demand release of a selective MMP-13 blocker from an enzyme-responsive injectable hydrogel protects cartilage from degenerative progression in osteoarthritis
Release of BI-4394, a MMP-13 inhibitor, from an enzyme-responsive hydrogel protects cartilage from progressive degeneration in an ACLT rat model.